[Ultraconservative treatment in stage I and II breast carcinoma. Results of a long-term follow-up on 500 operated breasts].
Identifieur interne : 005479 ( Main/Exploration ); précédent : 005478; suivant : 005480[Ultraconservative treatment in stage I and II breast carcinoma. Results of a long-term follow-up on 500 operated breasts].
Auteurs : R. Mencacci [Italie] ; L. Alessandroni ; G. Arcangeli ; R. Bertolini ; A. Cecera ; M. Lopez ; C. Mardarella ; A. Parisi ; R. TersigniSource :
- Minerva chirurgica [ 0026-4733 ] ; 2010.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle (anatomopathologie), Analyse de survie, Carcinomes (), Carcinomes (anatomopathologie), Carcinomes (mortalité), Carcinomes (radiothérapie), Dosimétrie en radiothérapie, Femelle, Humains, Hématome (étiologie), Lymphadénectomie (effets indésirables), Lymphoedème (étiologie), Mastectomie partielle (), Radiothérapie adjuvante, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Sérome (étiologie), Traitement médicamenteux adjuvant, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (mortalité), Tumeurs du sein (radiothérapie), Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Aisselle, Carcinomes, Tumeurs du sein.
- effets indésirables : Lymphadénectomie.
- mortalité : Carcinomes, Tumeurs du sein.
- radiothérapie : Carcinomes, Tumeurs du sein.
- étiologie : Hématome, Lymphoedème, Sérome.
- Adulte, Adulte d'âge moyen, Analyse de survie, Carcinomes, Dosimétrie en radiothérapie, Femelle, Humains, Mastectomie partielle, Radiothérapie adjuvante, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Traitement médicamenteux adjuvant, Tumeurs du sein, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Axilla (pathology), Breast Neoplasms (mortality), Breast Neoplasms (pathology), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Breast Neoplasms (therapy), Carcinoma (mortality), Carcinoma (pathology), Carcinoma (radiotherapy), Carcinoma (surgery), Carcinoma (therapy), Chemotherapy, Adjuvant, Female, Follow-Up Studies, Hematoma (etiology), Humans, Lymph Node Excision (adverse effects), Lymphedema (etiology), Mastectomy, Segmental (methods), Middle Aged, Neoplasm Staging, Radiotherapy Dosage, Radiotherapy, Adjuvant, Retrospective Studies, Seroma (etiology), Survival Analysis.
- MESH :
- adverse effects : Lymph Node Excision.
- etiology : Hematoma, Lymphedema, Seroma.
- methods : Mastectomy, Segmental.
- mortality : Breast Neoplasms, Carcinoma.
- pathology : Axilla, Breast Neoplasms, Carcinoma.
- radiotherapy : Breast Neoplasms, Carcinoma.
- surgery : Breast Neoplasms, Carcinoma.
- therapy : Breast Neoplasms, Carcinoma.
- Adult, Aged, Aged, 80 and over, Chemotherapy, Adjuvant, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Staging, Radiotherapy Dosage, Radiotherapy, Adjuvant, Retrospective Studies, Survival Analysis.
Abstract
Several randomized trials on conservative surgery compared with mastectomy in early-stage breast cancer have validated this technique in terms of local and distant relapse and survival of patients. Standard conservative approach includes surgical removal of the cancer with adequate cancer-free margins, axillary dissection, postoperative breast irradiation and adjuvant treatments when required.
PubMed: 20802429
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002950
- to stream PubMed, to step Curation: 002950
- to stream PubMed, to step Checkpoint: 002950
- to stream Ncbi, to step Merge: 003D57
- to stream Ncbi, to step Curation: 003D57
- to stream Ncbi, to step Checkpoint: 003D57
- to stream Main, to step Merge: 005526
- to stream Main, to step Curation: 005479
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Ultraconservative treatment in stage I and II breast carcinoma. Results of a long-term follow-up on 500 operated breasts].</title>
<author><name sortKey="Mencacci, R" sort="Mencacci, R" uniqKey="Mencacci R" first="R" last="Mencacci">R. Mencacci</name>
<affiliation wicri:level="3"><nlm:affiliation>Chirurgia Generale e Oncologica, Azienda Ospedaliera San Camillo-Forlanini, Roma, Italia. rmencacci@scamilloforlanini.rm.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Chirurgia Generale e Oncologica, Azienda Ospedaliera San Camillo-Forlanini, Roma</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alessandroni, L" sort="Alessandroni, L" uniqKey="Alessandroni L" first="L" last="Alessandroni">L. Alessandroni</name>
</author>
<author><name sortKey="Arcangeli, G" sort="Arcangeli, G" uniqKey="Arcangeli G" first="G" last="Arcangeli">G. Arcangeli</name>
</author>
<author><name sortKey="Bertolini, R" sort="Bertolini, R" uniqKey="Bertolini R" first="R" last="Bertolini">R. Bertolini</name>
</author>
<author><name sortKey="Cecera, A" sort="Cecera, A" uniqKey="Cecera A" first="A" last="Cecera">A. Cecera</name>
</author>
<author><name sortKey="Lopez, M" sort="Lopez, M" uniqKey="Lopez M" first="M" last="Lopez">M. Lopez</name>
</author>
<author><name sortKey="Mardarella, C" sort="Mardarella, C" uniqKey="Mardarella C" first="C" last="Mardarella">C. Mardarella</name>
</author>
<author><name sortKey="Parisi, A" sort="Parisi, A" uniqKey="Parisi A" first="A" last="Parisi">A. Parisi</name>
</author>
<author><name sortKey="Tersigni, R" sort="Tersigni, R" uniqKey="Tersigni R" first="R" last="Tersigni">R. Tersigni</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20802429</idno>
<idno type="pmid">20802429</idno>
<idno type="wicri:Area/PubMed/Corpus">002950</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002950</idno>
<idno type="wicri:Area/PubMed/Curation">002950</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002950</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002950</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002950</idno>
<idno type="wicri:Area/Ncbi/Merge">003D57</idno>
<idno type="wicri:Area/Ncbi/Curation">003D57</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003D57</idno>
<idno type="wicri:doubleKey">0026-4733:2010:Mencacci R:ultraconservative:treatment:in</idno>
<idno type="wicri:Area/Main/Merge">005526</idno>
<idno type="wicri:Area/Main/Curation">005479</idno>
<idno type="wicri:Area/Main/Exploration">005479</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Ultraconservative treatment in stage I and II breast carcinoma. Results of a long-term follow-up on 500 operated breasts].</title>
<author><name sortKey="Mencacci, R" sort="Mencacci, R" uniqKey="Mencacci R" first="R" last="Mencacci">R. Mencacci</name>
<affiliation wicri:level="3"><nlm:affiliation>Chirurgia Generale e Oncologica, Azienda Ospedaliera San Camillo-Forlanini, Roma, Italia. rmencacci@scamilloforlanini.rm.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Chirurgia Generale e Oncologica, Azienda Ospedaliera San Camillo-Forlanini, Roma</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alessandroni, L" sort="Alessandroni, L" uniqKey="Alessandroni L" first="L" last="Alessandroni">L. Alessandroni</name>
</author>
<author><name sortKey="Arcangeli, G" sort="Arcangeli, G" uniqKey="Arcangeli G" first="G" last="Arcangeli">G. Arcangeli</name>
</author>
<author><name sortKey="Bertolini, R" sort="Bertolini, R" uniqKey="Bertolini R" first="R" last="Bertolini">R. Bertolini</name>
</author>
<author><name sortKey="Cecera, A" sort="Cecera, A" uniqKey="Cecera A" first="A" last="Cecera">A. Cecera</name>
</author>
<author><name sortKey="Lopez, M" sort="Lopez, M" uniqKey="Lopez M" first="M" last="Lopez">M. Lopez</name>
</author>
<author><name sortKey="Mardarella, C" sort="Mardarella, C" uniqKey="Mardarella C" first="C" last="Mardarella">C. Mardarella</name>
</author>
<author><name sortKey="Parisi, A" sort="Parisi, A" uniqKey="Parisi A" first="A" last="Parisi">A. Parisi</name>
</author>
<author><name sortKey="Tersigni, R" sort="Tersigni, R" uniqKey="Tersigni R" first="R" last="Tersigni">R. Tersigni</name>
</author>
</analytic>
<series><title level="j">Minerva chirurgica</title>
<idno type="ISSN">0026-4733</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Axilla (pathology)</term>
<term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Carcinoma (mortality)</term>
<term>Carcinoma (pathology)</term>
<term>Carcinoma (radiotherapy)</term>
<term>Carcinoma (surgery)</term>
<term>Carcinoma (therapy)</term>
<term>Chemotherapy, Adjuvant</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Hematoma (etiology)</term>
<term>Humans</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphedema (etiology)</term>
<term>Mastectomy, Segmental (methods)</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Radiotherapy Dosage</term>
<term>Radiotherapy, Adjuvant</term>
<term>Retrospective Studies</term>
<term>Seroma (etiology)</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aisselle (anatomopathologie)</term>
<term>Analyse de survie</term>
<term>Carcinomes ()</term>
<term>Carcinomes (anatomopathologie)</term>
<term>Carcinomes (mortalité)</term>
<term>Carcinomes (radiothérapie)</term>
<term>Dosimétrie en radiothérapie</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hématome (étiologie)</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie partielle ()</term>
<term>Radiothérapie adjuvante</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Sérome (étiologie)</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Aisselle</term>
<term>Carcinomes</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hematoma</term>
<term>Lymphedema</term>
<term>Seroma</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mastectomy, Segmental</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Carcinomes</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Axilla</term>
<term>Breast Neoplasms</term>
<term>Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Carcinomes</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hématome</term>
<term>Lymphoedème</term>
<term>Sérome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Chemotherapy, Adjuvant</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Radiotherapy Dosage</term>
<term>Radiotherapy, Adjuvant</term>
<term>Retrospective Studies</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Carcinomes</term>
<term>Dosimétrie en radiothérapie</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mastectomie partielle</term>
<term>Radiothérapie adjuvante</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Several randomized trials on conservative surgery compared with mastectomy in early-stage breast cancer have validated this technique in terms of local and distant relapse and survival of patients. Standard conservative approach includes surgical removal of the cancer with adequate cancer-free margins, axillary dissection, postoperative breast irradiation and adjuvant treatments when required.</div>
</front>
</TEI>
<affiliations><list><country><li>Italie</li>
</country>
<region><li>Latium</li>
</region>
<settlement><li>Rome</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Alessandroni, L" sort="Alessandroni, L" uniqKey="Alessandroni L" first="L" last="Alessandroni">L. Alessandroni</name>
<name sortKey="Arcangeli, G" sort="Arcangeli, G" uniqKey="Arcangeli G" first="G" last="Arcangeli">G. Arcangeli</name>
<name sortKey="Bertolini, R" sort="Bertolini, R" uniqKey="Bertolini R" first="R" last="Bertolini">R. Bertolini</name>
<name sortKey="Cecera, A" sort="Cecera, A" uniqKey="Cecera A" first="A" last="Cecera">A. Cecera</name>
<name sortKey="Lopez, M" sort="Lopez, M" uniqKey="Lopez M" first="M" last="Lopez">M. Lopez</name>
<name sortKey="Mardarella, C" sort="Mardarella, C" uniqKey="Mardarella C" first="C" last="Mardarella">C. Mardarella</name>
<name sortKey="Parisi, A" sort="Parisi, A" uniqKey="Parisi A" first="A" last="Parisi">A. Parisi</name>
<name sortKey="Tersigni, R" sort="Tersigni, R" uniqKey="Tersigni R" first="R" last="Tersigni">R. Tersigni</name>
</noCountry>
<country name="Italie"><region name="Latium"><name sortKey="Mencacci, R" sort="Mencacci, R" uniqKey="Mencacci R" first="R" last="Mencacci">R. Mencacci</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005479 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005479 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:20802429 |texte= [Ultraconservative treatment in stage I and II breast carcinoma. Results of a long-term follow-up on 500 operated breasts]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20802429" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |